Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic factors in scleroderma.

D Briggs1, C Black, K Welsh

  • 1Department of Molecular Immunogenetics, Guy's Hospital, London.

Rheumatic Diseases Clinics of North America
|February 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A multi-centre real-world evaluation of AI-assisted organ at risk contouring on radiotherapy treatment planning workflows.

The British journal of radiology·2026
Same author

Rising seroprevalence of Borrelia spp. in free roaming felines in the eastern Tennessee valley.

Veterinary parasitology·2025
Same author

Comparing physiological impacts of positive pressure ventilation versus self-breathing via a versatile cardiopulmonary model incorporating a novel alveoli opening mechanism.

Computers in biology and medicine·2024
Same author

Molecular architecture of the ciliary tip revealed by cryo-electron tomography.

bioRxiv : the preprint server for biology·2023
Same author

Anaesthesia management of a child with aromatic L-amino acid decarboxylase deficiency.

Anaesthesia reports·2022
Same author

BSHI/BTS guidance on crossmatching before deceased donor kidney transplantation.

International journal of immunogenetics·2021
Same journal

Bridging the Divide in Global Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Foreword.

Rheumatic diseases clinics of North America·2026
Same journal

Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases.

Rheumatic diseases clinics of North America·2026
Same journal

Artificial Intelligence and Social Determinants of Health.

Rheumatic diseases clinics of North America·2026
Same journal

Updates in Ultrasound in Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Health Systems Strengthening to Promote Access to Care for Rheumatic and Musculoskeletal Diseases Globally.

Rheumatic diseases clinics of North America·2026
See all related articles

Genetic markers show limited overall association with systemic sclerosis (SSc) but are promising for diagnosing and predicting outcomes in specific patient subsets, particularly those with lung fibrosis. Further research into genetic links with collagen overproduction is needed for therapeutic breakthroughs.

Area of Science:

  • Immunogenetics
  • Rheumatology
  • Toxicology

Background:

  • Systemic sclerosis (SSc) lacks strong, universally applicable genetic markers for clinical use.
  • Specific patient subsets may exhibit significant associations with genetic markers, impacting diagnosis and prognosis.
  • Chemically induced SSc-like disorders share genetic links with classical SSc, exemplified by vinyl chloride disease.

Purpose of the Study:

  • To evaluate the clinical utility of genetic associations in systemic sclerosis (SSc).
  • To explore the diagnostic and prognostic potential of genetic markers in SSc subsets.
  • To investigate the relationship between genetic factors, autoantibody production, and collagen synthesis in SSc.

Main Methods:

  • Analysis of associations between SSc and major histocompatibility complex (MHC), T-cell receptors, and drug metabolism phenotypes.

Related Experiment Videos

  • Investigation of genetic markers in relation to specific SSc patient subsets, including lung fibrosis.
  • Examination of genetic markers in chemically induced SSc-like disorders.
  • Exploration of links between genetic markers, autoantibody production (e.g., anti-Scl-70), and collagen gene expression.

    • Main Results:

    • No single ethnic group shows a strong overall genetic association between SSc and MHC, T-cell receptors, or drug metabolism phenotypes for direct clinical application.
    • Emerging evidence suggests strong associations between specific genetic markers and autoantibody production in SSc, similar to findings in systemic lupus erythematosus (SLE).
    • Genetic markers may link chemically induced SSc-like conditions to classical SSc, with vinyl chloride disease as an example.

    Conclusions:

    • Genetic testing is expected to influence therapy for a subset of SSc patients.
    • Understanding the genetic basis of collagen overproduction is crucial for significant therapeutic advances in SSc.
    • Tentative links exist between MHC, chromosomal instability, and collagen gene expression via autoantibodies like anti-Scl-70, suggesting a complex genetic interplay in SSc pathogenesis.